GlassScriptPhysician profile
Erik J Sims
NPI 1831399252
$5,998.65
in general payments reported to CMS, 2019-2025
35 companies · $1,343 in 2025
The $1,343 reported for 2025 was more than what 75% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $643 · 2020: $402 · 2021: $901 · 2022: $542 · 2023: $801 · 2024: $1,367 · 2025: $1,343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,511.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,451.72 | 2019-2025 | Dart-Fire, Variax, Actishield |
| Smith+Nephew, INC. | $811.24 | 2019-2025 | Pico, Renasys Go V2 Home, Renasys Touch |
| Paratek Pharmaceuticals, INC. | $529.25 | 2020-2024 | Nuzyra |
| Next Science LLC | $374.56 | 2023-2024 | Blastx, Xperience, Surgx |
| Organogenesis INC. | $372.48 | 2019-2024 | Affinity, Puraply |
| Kci USA, INC. | $339.83 | 2019-2023 | Prevena, V.A.C. Dermatac, Activ.A.C. |
| Horizon Therapeutics Plc | $242.50 | 2019-2023 | Krystexxa |
| Abbvie INC. | $167.63 | 2022-2023 | Dalvance |
| Amgen INC. | $156.20 | 2024-2025 | Krystexxa |
| Advanced Oxygen Therapy INC. | $137.88 | 2021-2025 | Topical Oxygen Chamber For Extremities |
| Kerecis Limited | $135.27 | 2019-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Tactile Systems Technology INC | $119.10 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Bioventus LLC | $114.48 | 2022-2023 | Exogen Ultrasound Bone Healing System |
| Abbott Laboratories | $111.57 | 2025 | Axium |
| Reprise Biomedical, INC. | $91.80 | 2020-2024 | Miro3d |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $90.67 | 2023-2025 | Qutenza |
| Boston Scientific Corporation | $81.93 | 2024-2025 | General - Pain Management |
| Mimedx Group, INC. | $77.41 | 2024-2025 | |
| Treace Medical Concepts, INC. | $70.87 | 2024 | |
| Solventum Corporation | $67.55 | 2024-2025 | Activ.A.C., V.A.C. Dermatac, Promogran Prisma |
| Sandoz INC. | $59.42 | 2019 | |
| Alfasigma USA, INC. | $55.81 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $54.10 | 2019 | |
| Djo, LLC | $46.93 | 2024 | Cmf |
| Heron Therapeutics, INC. | $42.18 | 2021-2023 | Zynrelef |
| Medtronic, INC. | $31.16 | 2023 | Intellis Adaptivestim |
| Melinta Therapeutics, LLC | $26.52 | 2019 | |
| Ani Pharmaceuticals, INC. | $25.02 | 2024 | Purified Cortrophin Gel |
| Integra Lifesciences Corporation | $22.59 | 2021 | |
| Misonix INC | $17.92 | 2021 | |
| Wright Medical Technology, INC. | $16.82 | 2020 | |
| Hartmann USA, INC. | $16.55 | 2025 | Zetuvit Plus 10x10 P10 |
| Paragon 28, INC. | $14.29 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $13.70 | 2025 | |
| Grt US Holding, INC. | $11.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erik Sims listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.